Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 500mg and Rosuvastatin 10mg

NCT02011633 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus

Interventions

DRUG: HCP1201 500/10mg
DRUG: Metformin SR 500mg
DRUG: Rosuvastatin 10mg

Sponsor

Hanmi Pharmaceutical Company Limited